More Questions About COX-2 Arthritis Drugs

January 2005
Tufts University Health & Nutrition Letter;Jan2005, Vol. 22 Issue 11, p2
Reports on the clinical trials conducted to identify the role of arthritis medication COX-2 inhibitors in increasing the risk of heart attacks and strokes. Results of the clinical trial conducted by researcher Garret A. Fitzgerald on Bextra, a COX-2 painkiller from Pfizer; Position of Pfizer regarding the clinical trials, according to the company spokesperson; Evidence found from a test of COX-2 medications conducted on mice.


Related Articles

  • Officials Halt NSAID Prevention Trials. Hampton, Tracy // JAMA: Journal of the American Medical Association;2/9/2005, Vol. 293 Issue 6, p664 

    Reports that two government sponsored medical studies involving the use of NSAIDs have been halted after both showed that there was a greater risk of stroke and heart attacks in participants on the drugs; Use of celecoxib in a colorectal cancer study and an Alzheimer's Disease trial which...

  • Understanding the NSAID related risk of vascular events. Vonkeman, Harald E.; Brouwers, Jacobus R. B. J.; Van de Laar, Mart A. F. J. // BMJ: British Medical Journal (International Edition);4/15/2006, Vol. 332 Issue 7546, p895 

    The article examines the heightened risk of thrombotic events, such as myocardial infarction and stroke, for people using non-steroidal anti-inflammatory drugs, especially selective cyclo-oxygenase-2 (COX 2) inhibitors. Two selective COX 2 inhibitors are no longer available. Patients who have a...

  • Huge study questions HRT's role in heart health. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;5/30/2000, Vol. 162 Issue 11, p1603 

    Reports the results of a study done by the United States National Institute of Health (NIH) which found that women taking estrogen had more heart attacks, strokes and blood clots than women taking placebos. The number of women in the United States who are taking hormone replacement therapy...

  • Celebrex New ad, with questionable claims.  // Consumer Reports;Aug2007, Vol. 72 Issue 8, p52 

    This article explains that the Pfizer Company has omitted vital information from its advertisements for its pain-relieving product Celebrex. The advertisements suggest that Celebrex does not increase the risk of a heart attack or stroke any more than other nonsteroidal anti-inflammatory drugs....

  • When it comes to BP, low may not be low enough. Moore, Amy Slugg // RN;Dec98, Vol. 61 Issue 12, p18 

    Cites a study which found that patients have the least risk of heart attack or stroke and dying from either, when their diastolic blood pressure is below the recommended level. Finding from the Hypertension Optimal Treatment study; Evaluation of the benefits of adding low-dose aspirin to a...

  • Lose your temper--and your life?  // Consumer Reports on Health;Aug95, Vol. 7 Issue 8, p88 

    Reports on a study of 100 men which found a positive relationship between the anger scores from a psychological test taken in their twenties and the likelihood of having a heart attack or a stroke during midlife.

  • Aspirin prevents stroke, but not MI, in women.  // BMJ: British Medical Journal (International Edition);7/23/2005, Vol. 331 Issue 7510, p168 

    Presents the results of a study on the impact of aspirin on the risk for cardiovascular disease in women. Details of the study, which focused on middle-aged women with no history of cardiovascular disease; Details of the study's outcome; Report that aspirin reduces the risk of stroke and...

  • Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. Smeeth, Liam; Thomas, Sara L.; Hall, Andrew J.; Hubbard, Richard; Farrington, Paddy; Vallance, Patrick // New England Journal of Medicine;12/16/2004, Vol. 351 Issue 25, p2611 

    Background: There is evidence that chronic inflammation may promote atherosclerotic disease. We tested the hypothesis that acute infection and vaccination increase the short-term risk of vascular events. Methods: We undertook within-person comparisons, using the case-series method, to study the...

  • COX 2 inhibitors may increase risk of heart attack. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);9/1/2001, Vol. 323 Issue 7311, p471 

    Reports that certain cyclooxygenase (COX) 2 inhibitors, non-steroidal anti-inflammatory drugs that relieve the pain associated with arthritis, may increase the risk of heart attack. Research at the Cleveland Clinic Foundation in Ohio which compared cardiovascular events among patients taking...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics